Lake Street analyst Ryan Meyers lowered the firm’s price target on Joint Corp. (JYNT) to $11 from $16 and keeps a Buy rating on the shares. The transition toward a fully franchised model has taken longer than originally expected, says the analyst, who lowers the firm’s price target as the underlying fundamentals at the clinic level remain soft.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JYNT:
